Effect of antibiotics on gut microbiota, gut hormones and glucose metabolism

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Mikkelsen, Kristian H ^a,b   Frost, Morten ^c   Bahl, Martin I ^d   Licht, Tine R ^d   Jensen, Ulrich S ^a   Rosenberg, Jacob ^a   Pedersen, Oluf ^b   Hansen, Torben ^b,c   Rehfeld, Jens F ^a   Holst, Jens J ^b   Vilsbøll, Tina ^a   Knop, Filip K ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL HORMONE; GENTAMICIN; GLUCOSE; INSULIN; MEROPENEM; PEPTIDE YY; VANCOMYCIN; ANTIINFECTIVE AGENT; GLUCOSE BLOOD LEVEL; THIENAMYCIN DERIVATIVE;

ADULT; APPETITE; ARTICLE; BASAL METABOLIC RATE; BLADDER EMPTYING; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; FECES ANALYSIS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; INTESTINE FLORA; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; SPECIES COMPOSITION; STOMACH EMPTYING; ADOLESCENT; BACTERIAL LOAD; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; CLINICAL TRIAL; DIARRHEA; DIET RESTRICTION; DRUG EFFECTS; FECES; METABOLISM; MICROBIOLOGY; POSTPRANDIAL STATE; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BLOOD GLUCOSE; DIARRHEA; FASTING; FECES; GASTROINTESTINAL HORMONES; GASTROINTESTINAL MICROBIOME; GENTAMICINS; GLUCOSE; HUMANS; INSULIN; MALE; POSTPRANDIAL PERIOD; THIENAMYCINS; TIME FACTORS; TREATMENT OUTCOME; VANCOMYCIN; YOUNG ADULT;

EID: 84955594102     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142352     Document Type: Article

References (51)

1. Qin J, Li Y, Cai Z., Li S, Zhu J, Zhang F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490: 55-60. doi: 10.1038/nature11450 PMID: 23023125
2. Karlsson FH, Tremaroli V, Nookaew I., Bergström G, Behre C.J., Fagerberg B., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013; 498: 99-103. doi: 10.1038/nature12198 PMID: 23719380
3. Le Chatelier E., Nielsen T, Qin J., Prifti E, Hildebrand F, Falony G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500: 541-546. doi: 10.1038/nature12506 PMID: 23985870
4. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice. Science. 2013; 341:1241214-1241214. doi: 10.1126/science.1241214 PMID: 24009397
5. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte R.S., Bartelsman JFWM, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143: 913-916.e7. doi: 10.1053/j.gastro.2012.06.031 PMID: 22728514
6. Bäckhed F., Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004; 101:15718-15723. doi: 10.1073/pnas.0407076101 PMID: 15505215
7. Jernberg C, Löfmark S, Edlund C., Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007; 1: 56-66. doi: 10.1038/ismej.2007.3 PMID: 18043614
8. Jakobsson HE, Jernberg C, Andersson A.F., Sjölund-Karlsson M, Jansson JK, Engstrand L. Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome. 2010; 5: e9836.
9. Panda S, El khader I, Casellas F, Lopez Vivancos J, Garcia Cors M, Santiago A, et al Short-Term Effect of Antibiotics on Human Gut Microbiota. PLoSONE. 2014; 9. doi: 10.1371/journal.pone.0095476 PMID: 24748167
10. Dethlefsen L, Relman DA Colloquium Paper: Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci. 2010; 108: 4554-4561. doi: 10.1073/pnas.1000087107 PMID: 20847294
11. Thuny F, Richet H, Casalta J-P, Angelakis E, Habib G., Raoult D. Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity. Bereswill S, editor. PLoSONE. 2010; 5: e9074. doi: 10.1371/journal.pone.0009074 PMID: 20161775
12. Bailey LC, Forrest CB, Zhang P, Richards T.M., Livshits A., DeRusso PA. Association of Antibiotics in Infancy With Early Childhood Obesity. JAMAPediatr. 2014; doi: 10.1001/jamapediatrics.2014.1539 PMID: 25265089
13. Mikkelsen KH, Knop FK, Frost M, Hallas J., Pottegârd A. Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study. J Clin Endocrinol Metab. 2015; jc.2015-2696. doi:10.1210/jc.2015-2696
14. Chou H-W, Wang J-L, Chang C-H, Lee J-J, Shau W-Y, Lai M-S. Risk of Severe Dysglycemia Among Diabetic Patients Receiving Levofloxacin, Ciprofloxacin, or Moxifloxacin in Taiwan. Clin Infect Dis. 2013; 57: 971-980. doi: 10.1093/cid/cit439 PMID: 23948133
15. Francois F, Roper J, Joseph N., Pei Z, Chhada A, Shak JR, et al. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. BMC Gastroenterol. 2011; 11: 37. doi: 10.1186/1471-230X-11-37 PMID: 21489301
16. Vrieze A, Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol. 2014; 60: 824-831. doi: 10.1016/j.jhep.2013.11.034 PMID: 24316517
17. Parker BA, Sturm K, MacIntosh C.G., Feinle C., Horowitz M, Chapman IM. Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects. Eur J Clin Nutr. 2004; 58: 212-218. doi: 10.1038/sj.ejcn.1601768 PMID: 14749739
18. Flint A, Raben A, Blundell J.E., Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord J Int Assoc Study Obes. 2000; 24: 38-48.
19. Gregersen NT, Flint A, Bitz C, Blundell JE, Raben A, Astrup A. Reproducibility and power of ad libitum energy intake assessed by repeated single meals. Am J Clin Nutr. 2008; 87:1277-1281. PMID: 18469250
20. Daneman N, Sarwar S, Fowler RA, Cuthbertson BH, SuDDICU Canadian Study Group. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and metaanalysis. Lancet Infect Dis. 2013; 13: 328-341. doi: 10.1016/S1473-3099(12)70322-5 PMID: 23352693
21. D'Amico R., Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ. 1998; 316:1275-1285. PMID: 9554897
22. Rao S, Kupfer Y, Pagala M., Chapnick E, Tessler S. Systemic absorption of oral vancomycin in patients with Clostridium difficile infection. Scand J Infect Dis. 2011; 43: 386-388. doi: 10.3109/00365548.2010.544671 PMID: 21198337
23. Gemer O. Absorption of orally administered gentamicin in infants with diarrhea. Pediatr Pharmacol (New York). 1983; 3:119-23.
24. Saito T. Possible Factors Involved in Oral Inactivity of Meropenem, a Carbapenem Antibiotic. Pharmacol Amp Pharm. 2012; 03: 201-206. doi:10.4236/pp.2012.32027
25. Lewis SJ, Heaton KW Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997; 32: 920-924. PMID: 9299672
26. WHO | Diarrhoea. In: WHO [Internet]. Available: http://www.who.int/topics/diarrhoea/en/. Accessed 20 August 2013.
27. Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes. 1994; 43: 535-539. PMID: 8138058
28. Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem. 1998; 44: 991-1001. PMID: 9590372
29. Stadil F, Rehfeld JF Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol. 1973; 8:101-112. PMID: 4697070
30. Shipkova M, Petrova DT, Rosler AE, Orth M, Engelmayer J, Wieland E, et al. Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring. Ther DrugMonit. 2014; 36: 433-441. doi: 10.1097/FTD.0000000000000043 PMID: 24646729
31. Rose SB, Miller RE Studies with the Agar Cup-Plate Method: I. A Standardized Agar Cup-Plate Technique. J Bacteriol. 1939; 38: 525-537. PMID: 16560269
32. Dodds WJ, Groh WJ, Darweesh R.M., Lawson TL, Kishk SM, Kern MK. Sonographic measurement of gallbladder volume. Am J Roentgenol. 1985; 145:1009-1011.
33. Matsuda M, DeFronzo RA Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22:1462-1470. PMID: 10480510
34. Hanson RL, Pratley RE, Bogardus C, Narayan K.V., Roumain JM, Imperatore G, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemioiogic studies. Am J Epidemiol. 2000; 151:190-198. PMID: 10645822
35. Utzschneider KM, Prigeon RL, Faulenbach M.V., Tong J., Carr DB, Boyko EJ, et al. Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels. Diabetes Care. 2009; 32: 335-341. doi: 10.2337/dc08-1478 PMID: 18957530
36. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J Off Publ Fed Am Soc Exp Biol. 2008; 22: 2416-2426. doi:10.1096/fj.07-102723
37. Carvalho BM, Guadagnini D, Tsukumo DML, Schenka AA, Latuf-Filho P, Vassallo J, et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia. 2012; doi: 10.1007/s00125-012-2648-4 PMID: 22828956
38. Cho I, Yamanishi S, Cox L., Methé BA, Zavadil J, Li K, et al. Antibiotics in early life alterthe murine colonic microbiome and adiposity. Nature. 2012; 488: 621-626. doi: 10.1038/nature11400 PMID: 22914093
39. Reijnders D, Goosens G, Neis E., Van der Beek K, Most J, Holst J, et al. Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans. Poster presentation presented at: EMBL Conference on the Human Microbiome; 2015 Jun; Heidelberg, Germany.
40. Sayin SI, Wahlström A, Felin J., Jäntti S, Marschall H-U, Bamberg K, et al Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist. Cell Metab. 2013; 17: 225-235. doi: 10.1016/j.cmet.2013.01.003 PMID: 23395169
41. Cani PD, Amar J, Iglesias M.A., Poggi M., Knauf C, Bastelica D, et al Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007; 56:1761-1772. doi: 10.2337/db06-1491 PMID: 17456850
42. Cummings JH, Pomare EW, Branch W.J., Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987; 28:1221-1227. PMID: 3678950
43. Wichmann A, Allahyar A, Greiner TU, Plovier H, Lundén GÖ, Larsson T, et al. Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit. Cell Host Microbe. 2013; 14: 582-590. doi: 10.1016/j.chom.2013.09.012 PMID: 24237703
44. Woods SC, D'Alessio DA. Central Control of Body Weight and Appetite. J Clin Endocrinol Metab. 2008; 93: s37-s50. doi: 10.1210/jc.2008-1630 PMID: 18987269
45. El-Salhy M., Mazzawi T, Gundersen D, Hatlebakk JG, Hausken T. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. BMC Res Notes. 2013; 6: 391. doi: 10.1186/1756-0500-6-391 PMID: 24073715
46. Wichmann A, Allahyar A, Greiner TU, Plovier H, Lundén GÖ, Larsson T, et al. Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit. Cell Host Microbe. 2013; 14: 582-590. doi: 10.1016/j.chom.2013.09.012 PMID: 24237703
47. Moriya R, Shirakura T, Hirose H, Kanno T, Suzuki J, Kanatani A. NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice. Peptides. 2010; 31: 671-675. doi: 10.1016/j.peptides.2009.11.005 PMID: 19925840
48. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebioticeffects: metabolic and health benefits. Br J Nutr. 2010; 104 Suppl 2: S1-63. doi: 10.1017/S0007114510003363 PMID: 20920376
49. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al. Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2. Diabetes. 2011; 61: 364-371. doi: 10.2337/db11-1019 PMID: 22190648
50. Trasande L, Blustein J, Liu M., Corwin E, Cox LM, Blaser MJ Infant antibiotic exposures and early-life body mass. Int J Obes2005. 2012; doi: 10.1038/ijo.2012.132
51. Visscher TLS, Seidell JC. Time trends (1993-1997) and seasonal variation in body mass index and waist circumference in the Netherlands. Int J Obes. 2004; 28:1309-1316. doi:10.1038/sj.ijo.0802761